Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMarmara University

About this trial

Radiofrequency ablation and phenol neurolysis of the ganglion impar are methods used in cases unresponsive to medication, particularly in patients who derive short-term or partial relief from the initial ganglion impar block. In clinical practice, clinicians frequently use these two injections in patients with treatment-resistant pain who only partially benefit from the initial blockade procedure.

To date, the medical literature lacks a comprehensive study comparing the efficacy of radiofrequency ablation and phenol neurolysis in patients who partially benefit from ganglion impar block. Therefore, this study is designed to compare the effectiveness of these two methods in patients with chronic coccydynia.

Eligibility criteria

Qualifiers

Age between 18 and 65 years

Presence of chronic coccydynia lasting at least 3 months

Pre-procedural pain score of 4 or higher on the Numeric Rating Scale (NRS)

Patients who have undergone a ganglion impar block within the last 3 months and experienced limited benefit (i.e., less than 50% reduction in pain compared to pre-treatment) and/or short-term relief (less than 4 weeks)

Disqualifiers

History of surgery involving the sacrococcygeal region

Prior treatment with ganglion impar phenol neurolysis or radiofrequency ablation

Coagulopathies (bleeding disorders)

Infection

Trial design

Treatments tested in this trial

  • Phenol Injection
  • Radiofrequency ablation alone

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators